These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 3116203)
1. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart. Wang JX; Mei L; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203 [TBL] [Abstract][Full Text] [Related]
2. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart. Mei L; Wang JX; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1987 Sep; 242(3):991-1000. PubMed ID: 3656121 [TBL] [Abstract][Full Text] [Related]
3. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
6. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [TBL] [Abstract][Full Text] [Related]
7. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
11. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA; Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [TBL] [Abstract][Full Text] [Related]
12. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W; Wolfe BB Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [TBL] [Abstract][Full Text] [Related]
13. Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung. Bloom JW; Halonen M; Yamamura HI J Pharmacol Exp Ther; 1988 Feb; 244(2):625-32. PubMed ID: 3346839 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic characterization of muscarinic receptors of insect brains. Abdallah EA; Eldefrawi ME; Eldefrawi AT Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028 [TBL] [Abstract][Full Text] [Related]
15. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors. Harden TK; Meeker RB; Martin MW J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839 [TBL] [Abstract][Full Text] [Related]
16. Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstem. Flynn DD; Potter LT Mol Pharmacol; 1986 Sep; 30(3):193-9. PubMed ID: 3092026 [TBL] [Abstract][Full Text] [Related]
17. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
18. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
19. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Ladner CJ; Lee JM Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152 [TBL] [Abstract][Full Text] [Related]
20. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]